Editorial Perspectives On Data Management & Analysis

  1. Pharma's Investment In RWE Is Beginning To Pay Off 7/7/2020

    For years the life sciences industry has heard about the benefits of investing in real-world evidence (RWE) and real-world data (RWD). According to a recent report from Deloitte, that investment may finally be paying off for companies that climbed onboard and have been building those capabilities.

  2. Teva Develops First FDA-Approved Digitally-Integrated Inhaler 1/8/2020

    Two challenges have plagued asthma sufferers and researchers for year. The first is patients not adhering to their maintenance medication. The other is patients not using proper inhaler technique. A new digitally-integrated inhaler from Teva hopes to eliminate both problems.

  3. BMS-Pfizer Alliance Evaluates AFib Screening And Stroke Connection 12/10/2019

    In November 2019, the BMS-Pfizer Alliance announced the initiation of a new randomized, controlled study called GUARD-AF. The trial will evaluate whether atrial fibrillation (AFib) screening can ultimately impact the rate of stroke, compared to standard medical care in older individuals in a real-world setting.

  4. Study Reveals Nearly $215 Billion Economic Burden Of Nocturia 12/3/2019

    Dr. Jay Jhaveri, lead investigator for Ferring Pharmaceuticals, knew that nocturia was a burden to many patients and to the U.S. economy. Unfortunately, no HEOR existed for nocturia. For that reason, Ferring decided to produce its own. To get the real-world information it needed on the prevalence of the condition, the company turned to the National Health and Nutrition Examination Survey (NHANES).

  5. Can Activity Trackers Create Better Clinical Trials? 9/6/2018

    I recently reported on data collected from Fitbit activity trackers. Fitbit has compiled 150 billion hours of data on the resting heart rate (RHR) of tens of millions of people around the world who used a Fitbit. Can this type of data help researchers, especially cardiologists, conduct better clinical trials on heart patients in the future?

  6. Three Ways To Improve Quality In Clinical Trial Processes 10/24/2017

    Timeliness, cost, and quality are all critical factors that must come together to ensure an efficient and successful clinical trial. Unfortunately, the complexity of trials, combined with coordination challenges, force sponsors to have to identify the opportunities needed to improve trials. But how do you know what efforts will produce the best results?

  7. Will Liquid Biopsies Transform Oncology Clinical Trials? 7/29/2016

    Epic Sciences says it has developed a technology that CEO Murali Prahalad believes will transform oncology trials by identifying and characterizing circulating tumor cells. Those cells have been long recognized as a key part of cancer metastasis. Tumors shed these cells into the circulatory system where they then travel to different parts of the body and, under the right conditions, become the genesis of new tumors.